Liraglutide
Green
Brand:
Victoza®
Nice TA:
NG28
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
NICE TA203 replaced by NICE NG28
The LSCMMG recommends liraglutide (Victoza®) as the 2nd line GLP‑1 agonist (1st line — dulaglutide or weekly exenatide)
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: